世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3908 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、モノクローナル抗体治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト化抗体、ヒトマウスキメラ抗体）、用途別市場規模（がん、自己免疫疾患、感染症、造血系疾患、眼科疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・モノクローナル抗体治療の市場動向 ・企業の競争状況、市場シェア ・モノクローナル抗体治療の種類別市場規模（ヒト化抗体、ヒトマウスキメラ抗体） ・モノクローナル抗体治療の用途別市場規模（がん、自己免疫疾患、感染症、造血系疾患、眼科疾患、その他） ・モノクローナル抗体治療の北米市場規模2016-2027（アメリカ、カナダ） ・モノクローナル抗体治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・モノクローナル抗体治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・モノクローナル抗体治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・モノクローナル抗体治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、F. Hoffmann-La Roche、Pfizer、Sanofi、GlaxoSmithKline、Merck、Novartis、AbbVie、Amgen、Johnson & Johnson、Bristol-Myers Squibb Company、Biogen） ・結論

Market Analysis and Insights: Global Monoclonal Antibody Therapeutics Market
The global Monoclonal Antibody Therapeutics market size is projected to reach US$ 178100 million by 2026, from US$ 109280 million in 2019, at a CAGR of 7.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monoclonal Antibody Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monoclonal Antibody Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monoclonal Antibody Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monoclonal Antibody Therapeutics market.

Global Monoclonal Antibody Therapeutics Scope and Market Size
Monoclonal Antibody Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Humanized Antibody
Human Mouse Chimeric Antibody

Segment by Application
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2016-2027)
2.2 Monoclonal Antibody Therapeutics Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Therapeutics Industry Dynamic
2.3.1 Monoclonal Antibody Therapeutics Market Trends
2.3.2 Monoclonal Antibody Therapeutics Market Drivers
2.3.3 Monoclonal Antibody Therapeutics Market Challenges
2.3.4 Monoclonal Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2020
3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027)

5 Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2016-2027)
6.2 North America Monoclonal Antibody Therapeutics Market Size by Type
6.2.1 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Application
6.3.1 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country
6.4.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type
7.2.1 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application
7.3.1 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country
7.4.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type
9.2.1 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application
9.3.1 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country
9.4.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.12.5 Biogen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Humanized Antibody
Table 3. Key Players of Human Mouse Chimeric Antibody
Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Monoclonal Antibody Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Table 10. Monoclonal Antibody Therapeutics Market Trends
Table 11. Monoclonal Antibody Therapeutics Market Drivers
Table 12. Monoclonal Antibody Therapeutics Market Challenges
Table 13. Monoclonal Antibody Therapeutics Market Restraints
Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Monoclonal Antibody Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020)
Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Date of Enter into Monoclonal Antibody Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Monoclonal Antibody Therapeutics Product
Table 64. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
Table 69. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Monoclonal Antibody Therapeutics Product
Table 74. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Monoclonal Antibody Therapeutics Product
Table 79. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Monoclonal Antibody Therapeutics Product
Table 89. Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Monoclonal Antibody Therapeutics Product
Table 94. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 99. AbbVie Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Monoclonal Antibody Therapeutics Product
Table 103. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Amgen Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Monoclonal Antibody Therapeutics Product
Table 108. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Johnson & Johnson Recent Development
Table 110. Bristol-Myers Squibb Company Company Details
Table 111. Bristol-Myers Squibb Company Business Overview
Table 112. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
Table 113. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Bristol-Myers Squibb Company Recent Development
Table 115. Biogen Company Details
Table 116. Biogen Business Overview
Table 117. Biogen Monoclonal Antibody Therapeutics Product
Table 118. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Biogen Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Humanized Antibody Features
Figure 3. Human Mouse Chimeric Antibody Features
Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Autoimmune Diseases Case Studies
Figure 7. Infection Case Studies
Figure 8. Hematological Diseases Case Studies
Figure 9. Ophthalmological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Monoclonal Antibody Therapeutics Market Share by Players in 2020
Figure 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2020
Figure 19. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2016-2027)
Figure 41. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 71. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---